tiprankstipranks
Trending News
More News >
X4 Pharmaceuticals Inc (XFOR)
NASDAQ:XFOR
US Market

X4 Pharmaceuticals (XFOR) Income Statement

Compare
980 Followers

X4 Pharmaceuticals Income Statement

Last quarter (Q3 2024), X4 Pharmaceuticals's total revenue was $560.00K, an increase of Infinity% from the same quarter last year. In Q3, X4 Pharmaceuticals's net income was $-36.70M. See X4 Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.56M$ 0.00$ 0.00$ 0.00$ 3.00M
Gross Profit
$ 1.76M$ -2.00M$ -1.99M$ -1.89M$ 3.00M
Operating Expenses
$ 143.16M$ 107.52M$ 88.08M$ 75.35M$ 62.87M
Depreciation and Amortization
$ 0.00$ 419.00K$ 1.99M$ 1.89M$ 1.23M
EBITDA
$ -36.40M$ -107.10M$ -87.57M$ -85.11M$ -58.06M
Operating Income
$ -36.40M$ -107.52M$ -87.57M$ -85.11M$ -59.87M
Other Income/Expenses
$ -739.00K$ 6.43M$ -6.27M$ -3.57M$ -2.11M
Pretax Income
$ -37.14M$ -101.09M$ -93.84M$ -88.68M$ -61.98M
Net Income
$ -37.45M$ -101.17M$ -93.87M$ -88.70M$ -62.13M
Per Share Metrics
Basic EPS
$ -0.19$ -0.57$ -1.48$ -3.44$ -3.09
Diluted EPS
$ -0.19$ -0.57$ -1.48$ -3.44$ -3.09
Weighted Average Shares Outstanding
201.06M 177.81M 63.53M 25.75M 20.08M
Weighted Average Shares Outstanding (Diluted)
201.06M 177.81M 63.53M 25.75M 20.08M
Currency in USD

X4 Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis